However, the complement regulatory proteins CD59, CD46, decay accelerating factor, and complement receptor type 1 (CR1) are lower in the ADEs of patients with AD than in healthy controls and decrease further with disease progression. This evidence concerns the gene CR1 and Alzheimer disease.